Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
[Corrigendum] LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling. [electronic resource] by
- Xiao, Qungen
- Dong, Minhai
- Cheng, Fangling
- Mao, Feng
- Zong, Weifeng
- Wu, Kang
- Wang, Heping
- Xie, Ruifan
- Wang, Baofeng
- Lei, Ting
- Guo, Dongsheng
Publication details: International journal of oncology 06 2019
In:
International journal of oncology vol. 54
Availability: No items available.
|
|
6.
|
LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling. [electronic resource] by
- Xiao, Qungen
- Dong, Minhai
- Cheng, Fangling
- Mao, Feng
- Zong, Weifeng
- Wu, Kang
- Wang, Heping
- Xie, Ruifan
- Wang, Baofeng
- Lei, Ting
- Guo, Dongsheng
Producer: 20181126
In:
International journal of oncology vol. 53
Availability: No items available.
|
|
7.
|
The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma. [electronic resource] by
- Cheng, Fangling
- Zhang, Po
- Xiao, Qungen
- Li, Youwei
- Dong, Minhai
- Wang, Heping
- Kuang, Dong
- He, Yue
- Duan, Qiuhong
- Mao, Feng
- Wang, Baofeng
- Guo, Dongsheng
Publication details: Frontiers in oncology 2019
In:
Frontiers in oncology vol. 9
Availability: No items available.
|
|
8.
|
Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling. [electronic resource] by
- Dong, Minhai
- Xiao, Qungen
- Hu, Jinyang
- Cheng, Fangling
- Zhang, Po
- Zong, Weifeng
- Tang, Qiaoying
- Li, Xiaopeng
- Mao, Feng
- He, Yue
- Yu, Xingjiang
- Wan, Feng
- Lei, Ting
- Guo, Dongsheng
- Wang, Baofeng
Producer: 20211221
In:
Cancer gene therapy vol. 27
Availability: No items available.
|